Lexaria Bioscience Corp (LEXX)

[damAcon1]

2021-04-26 10:00:00 - Lexaria Bioscience Corp (NASDQ:LEXX) (Nasdaq:LEXXW) (CSE:LXX),, a global innovator in drug delivery platforms, has announced it has issued stock options to consultants, employees, directors and officers. Lexaria has issued 43,500 stock options at an exercise price of US$5.31; and 26,000 stock options to an executive officer who also holds over 10% of the company’s issued share capital for the purchase of up to 26,000 shares at an exercise price of US$5.83. The options are exercisable for a period of five years expiring on April 26, 2026, with some issuances being subject to certain vesting provisions. The option shares will be subject to a four month hold period as prescribed by Canadian Securities Exchange policies.

https://www.proactiveinvestors.com/companies/amp/news/947643